These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6305834)

  • 1. Effects of leukocyte inhibitory factor (LIF) on human neutrophil function.
    Klempner MS; Rocklin RE
    Inflammation; 1983 Jun; 7(2):145-53. PubMed ID: 6305834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological studies with human leukocyte inhibitory factor.
    Borish LC; Rocklin RE
    Surv Immunol Res; 1985; 4(3):230-7. PubMed ID: 3003858
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of the function of neutrophil type-1 and type-3 complement receptors by human leukocyte inhibitory factor (LIF).
    Borish L; Audera C; Rosenbaum R; Rocklin RE
    Cell Immunol; 1988 May; 113(2):320-8. PubMed ID: 2834072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of leukocyte inhibitory factor (LIF) on neutrophil phagocytosis and bactericidal activity.
    Borish L; Rocklin RE
    J Immunol; 1987 Mar; 138(5):1475-9. PubMed ID: 2949016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
    Webster RO; Goldstein IM; Flick MR
    J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of neutrophil superoxide production by fanetizole.
    Styrt B; Rocklin RE; Klempner MS
    Inflammation; 1985 Sep; 9(3):233-44. PubMed ID: 2995253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil response to LIF: lack of glucocorticoid effect despite enhanced chemokinesis.
    Lurie DP; DeLustro F; LeRoy EC
    Inflammation; 1983 Mar; 7(1):49-56. PubMed ID: 6301986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological studies with human leukocyte inhibitory factor.
    Borish L; Rocklin R
    Immunol Ser; 1992; 57():373-85. PubMed ID: 1504141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of leukotrienes on neutrophil migration, and on production and action of lymphokines.
    Svenson M; Bisgaard H; Bendtzen K
    Allergy; 1984 Aug; 39(6):481-4. PubMed ID: 6093614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes.
    Seligmann BE; Fletcher MP; Gallin JI
    J Immunol; 1983 Apr; 130(4):1902-9. PubMed ID: 6131922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific binding of leukocyte inhibitory factor to neutrophil plasma membranes.
    Klempner MS; Rocklin RE
    J Immunol; 1982 May; 128(5):2040-3. PubMed ID: 7037959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial removal of sialic acid enhances phagocytosis and the generation of superoxide and chemiluminescence by polymorphonuclear leukocytes.
    Henricks PA; van Erne-van der Tol ME; Verhoef J
    J Immunol; 1982 Aug; 129(2):745-50. PubMed ID: 6282969
    [No Abstract]   [Full Text] [Related]  

  • 13. Generation of an eosinophilotactic factor from human PMNS by various mechanisms of cell activation.
    König W; Frickhofen N; Tesch H
    Adv Exp Med Biol; 1979; 114():521-8. PubMed ID: 380300
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of benoxaprofen on human neutrophil function.
    Turner RA; Semble EL; Johnson JA; McCrickard EL; Treadway WJ; Kaufmann JS
    J Rheumatol; 1984 Jun; 11(3):265-71. PubMed ID: 6737371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human interleukin-11 does not affect functions of purified human neutrophils in vitro.
    Bozza M; Kyvelos D; Trepicchio WL; Collins M; Klempner MS; Dorner AJ
    J Interferon Cytokine Res; 1998 Oct; 18(10):889-95. PubMed ID: 9809625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus-stimulated mononuclear leucocyte-conditioned medium increases the neutrophil bactericidal activity, and augments oxygen radical production and degranulation in response to the bacteria.
    Ferrante A; Harvey DP; Bates EJ
    Clin Exp Immunol; 1989 Dec; 78(3):366-71. PubMed ID: 2558821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between human polymorphonuclear leucocytes and Staphylococcus aureus in the presence and absence of opsonins.
    Vandenbroucke-Grauls CM; Thijssen HM; Verhoef J
    Immunology; 1984 Jul; 52(3):427-35. PubMed ID: 6086502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opsonization of Staphylococcus aureus protects endothelial cells from damage by phagocytosing polymorphonuclear leukocytes.
    Vandenbroucke-Grauls CM; Thijssen HM; Verhoef J
    Infect Immun; 1987 Jun; 55(6):1455-60. PubMed ID: 3032800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.
    Goetzl EJ; Rocklin RE
    J Immunol; 1978 Sep; 121(3):891-6. PubMed ID: 690441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release.
    Conti P; Barbacane RC; Reale M; Panara MR; Placido FC; Mier JW; Castracane JM; Dempsey RA
    Biotechnol Ther; 1993; 4(3-4):239-52. PubMed ID: 8292972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.